Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues. (Q37431500)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

review article

1 reference

title

Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Lars Jordheim

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

C Hébrard

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

1 reference

3 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

541-550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Current progress in suicide gene therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Cloning and expression of human deoxycytidine kinase cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Enhancement of cytarabine sensitivity in squamous cell carcinoma cell line transfected with deoxycytidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Human deoxycytidine kinase is located in the cell nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

The subcellular location of nucleoside analog phosphorylation is a determinant of synergistic effects of hydroxyurea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Adenoviral vector transduction of the human deoxycytidine kinase gene enhances the cytotoxic and radiosensitizing effect of gemcitabine on experimental gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Structure of human dCK suggests strategies to improve anticancer and antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Four deoxynucleoside kinase activities from Drosophila melanogaster are contained within a single monomeric enzyme, a new multifunctional deoxynucleoside kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Transient expression of Drosophila melanogaster deoxynucleoside kinase gene enhances cytotoxicity of nucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Altered deoxyribonucleotide pools in T-lymphoblastoid cells expressing the multisubstrate nucleoside kinase of Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Functional studies of active-site mutants from Drosophila melanogaster deoxyribonucleoside kinase. Investigations of the putative catalytic glutamate-arginine pair and of residues responsible for substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Active site mutants of Drosophila melanogaster multisubstrate deoxyribonucleoside kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

A few amino acid substitutions can convert deoxyribonucleoside kinase specificity from pyrimidines to purines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Non-homologous recombination of deoxyribonucleoside kinases from human and Drosophila melanogaster yields human-like enzymes with novel activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Gene therapy with drug resistance genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Hematopoietic stem cell gene therapy with drug resistance genes: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Recombinant human cytidine deaminase: expression, purification, and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Forced expression of cytidine deaminase confers sensitivity to capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Transfer of the cytidine deaminase cDNA into hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Cloning and characterization of an alternative splicing transcript of the gene coding for human cytidine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Modulation of human cytidine deaminase by specific aminoacids involved in the intersubunit interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Action of troxacitabine on cells transduced with human cytidine deaminase cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Eclipsing Binary Model of Cygnus XR-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

Purine nucleoside phosphorylase. VI. Microheterogeneity and comparison of kinetic behavior of the enzyme from several tissues and species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

7 January 2021

Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

7 January 2021

Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

7 January 2021

Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

7 January 2021

Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

7 January 2021

Assessment of resistance induction to cytosine arabinoside following transfer and overexpression of the deoxycytidylate deaminase gene in vitro

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

7 January 2021

Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.25

7 January 2021

Identifiers

DOI

10.1038/CGT.2009.25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343063%20AND%20SRC:MED&resulttype=core&format=json

release_nzj5ouhcqfc53ano2754tm37gy

25 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nzj5ouhcqfc53ano2754tm37gy

24 November 2022

mapped directly with Wikidata item

1 reference